
Sailong Pharmaceutical Group Co., Ltd. — Investor Relations & Filings
Sailong Pharmaceutical Group Co., Ltd. is a pharmaceutical enterprise focused on the research, development, production, and marketing of high-end generic drugs and innovative formulations. The company maintains an integrated industrial chain encompassing active pharmaceutical ingredients (APIs) and finished dosage forms. Its product portfolio primarily targets therapeutic areas such as cardiovascular and cerebrovascular diseases, the digestive system, and anti-infective treatments. Key products include Monosialotetrahexosylganglioside Sodium Injection and Pantoprazole Sodium for Injection. The group emphasizes technological innovation and quality control to provide clinical solutions for complex medical conditions.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 关于续聘公司2025年度审计机构的公告 | 2025-09-12 | Chinese | |
| 第四届董事会审计委员会2025年第四次会议的审查意见 | 2025-09-12 | Chinese | |
| 第四届董事会提名委员会2025年第二次会议审查意见 | 2025-09-12 | Chinese | |
| 信息披露暂缓与豁免管理制度 | 2025-09-12 | Chinese | |
| 关于子公司停产检修完成暨复产的公告 | 2025-09-01 | Chinese | |
| 董事会审计委员会关于公司计提减值准备事项合理性的说明 | 2025-08-27 | Chinese |
Browse filings by year
10 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 38450496 | 关于续聘公司2025年度审计机构的公告 | 2025-09-12 | Chinese | ||
| 38450480 | 第四届董事会审计委员会2025年第四次会议的审查意见 | 2025-09-12 | Chinese | ||
| 38450466 | 第四届董事会提名委员会2025年第二次会议审查意见 | 2025-09-12 | Chinese | ||
| 38450450 | 信息披露暂缓与豁免管理制度 | 2025-09-12 | Chinese | ||
| 38450431 | 关于子公司停产检修完成暨复产的公告 | 2025-09-01 | Chinese | ||
| 38450419 | 董事会审计委员会关于公司计提减值准备事项合理性的说明 | 2025-08-27 | Chinese | ||
| 38450411 | 半年报董事会决议公告 | 2025-08-27 | Chinese | ||
| 38450398 | 2025年半年度财务报告 | 2025-08-27 | Chinese | ||
| 38450297 | 关于2025年半年度计提资产减值准备的公告 | 2025-08-27 | Chinese | ||
| 38450288 | 2025年半年度报告摘要 | 2025-08-27 | Chinese | ||
| 38450263 | 半年度非经营性资金占用及其他关联资金往来情况汇总表 | 2025-08-27 | Chinese | ||
| 38450249 | 半年报财务报表 | 2025-08-27 | Chinese | ||
| 38450211 | 2025年半年度报告 | 2025-08-27 | Chinese | ||
| 38450160 | 第四届董事会审计委员会2025年第三次会议的审查意见 | 2025-08-27 | Chinese | ||
| 38450149 | 关于公司选举法定代表人的公告 | 2025-08-27 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Sailong Pharmaceutical Group Co., Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/54895/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=54895 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=54895 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=54895 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 54895}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Sailong Pharmaceutical Group Co., Ltd. (id: 54895)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.